Grid Biosciences Hong Kong Limited is a biotechnology company focused on the development of prophylactic and therapeutic vaccines for Difficult-to-Treat Diseases. Grid is developing a vaccine against Epstein-Barr virus (EBV) and downstream diseases, including nasopharyngeal carcinoma, gastric cancer, infectious mononucleosis, and multiple sclerosis.
福萊事診斷有限公司
FLASH Diagnostics Limited is a Hong Kong-based biotechnology start-up developing molecular diagnostics solutions for the veterinary industry,…
水中銀(國際)生物科技有限公司
Vitargent was established in 2010 under the mission of “Safer Products. Better World”. Vitargent is led by an experienced management and R&D team,…
Innorna is a clinical-stage biotechnology company engineering mRNA-based medicines to treat chronic diseases, power in vivo immunotherapies, and…
VET is founded by Professor H. Meng and her students. The team has a long history of research in speech-related AI technologies. VET focuses on…
奧朗生物醫藥有限公司
Alephoson Biopharmaceuticals Limited (AB) is a private, technology-based company focusing on research and development of innovative drug delivery…
依诺科技（香港）有限公司
InnoDrug Lab. (Hongkong) Co., Ltd was founded by Prof. Yi Zhun ZHU, a Singaporean attracted by the "talented program" by the HK government, who has…
